Research

Emerging artificial intelligence methods to assess transfusion quality

Emerging artificial intelligence methods to assess transfusion quality

Research from Dr. Hongshen Ma’s lab describes how machine learning and artificial intelligence can help assess transfusion quality.

Dr. Leonard Foster shows federal Minister Harjit Sajjan how his lab is working to improve the delivery technology behind mRNA vaccines.

CBR scientists receive federal support to advance mRNA vaccine technologies

Dr. Leonard Foster and Dr. Natalie Strynadka have received $11.1 million for research on the delivery and efficacy of mRNA vaccines.

“Squeeze-ability” of a red blood cell: The deformability of red blood cells is a useful biomarker for storage quality

“Squeeze-ability” of a red blood cell: The deformability of red blood cells is a useful biomarker for storage quality

CBR scientists found that red blood cell deformability – its ability to squeeze and change shape – could be a useful biomarker for storage quality.

Dr. Kelly Brown leads evaluation of the utility of adult-defined biomarkers in pediatric vasculitis with CIHR Fall 2021 Project Grant

Dr. Kelly Brown leads evaluation of the utility of adult-defined biomarkers in pediatric vasculitis with CIHR Fall 2021 Project Grant

With a CIHR Fall 2021 Project Grant, Dr. Kelly Brown is leading a project to better understand and treat pediatric vasculitis.

UBC 3MT finalist calls for more science communication

UBC 3MT finalist calls for more science communication

UBC 3MT finalist Nicolas Pereyra shares his research on extending the shelf-life of platelets, and thoughts on science communication.

Dr. Narges Hadjesfandiari, Dr. Katherine Serrano and Dr. Elena Levin are pictured in Dr. Dana Devine’s lab at the Centre for Blood Research.

Research answers questions about infusion pumps’ effect on red blood cells

A study from Dr. Narges Hadjesfandiari and colleagues investigates infusion pumps’ effect on red blood cells.

Cancer drug shows potential as treatment for muscular dystrophy

Cancer drug shows potential as treatment for muscular dystrophy

UBC researchers have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy.

Fine-tuning fibrin(ogen)

Fine-tuning fibrin(ogen)

In a recent paper, Kastrup Lab members have devised a strategy to modulate fibrinogen expression using LNP delivery of siRNAs.

“Accelerating science”: The development of Isolatrix for single cell isolation

“Accelerating science”: The development of Isolatrix for single cell isolation

Researchers from Dr. Karen Cheung’s lab are developing Isolatrix, an innovative instrument that performs highly precise single cell isolation.

A day in the life of a honeybee scientist

A day in the life of a honeybee scientist

With photos and writing, Rhonda Thygesen gives a unique look into the daily life of honeybee scientist Abigail Chapman.